Showing results (21-30 of 112) with videos related to
Sort By:
Pageof 12
Prostate International|January 24, 2020
Prognostic significance of diabetes mellitus and dyslipidemia in men receiving androgen-deprivation therapy for metastatic prostate cancerYu Hirata, Masaki Shiota, Takeshi Kobayashi, et al.Journal of Cancer Research and Clinical Oncology|September 18, 2014
The oncological outcome and validation of Japan Cancer of the Prostate Risk Assessment score among men treated with primary androgen-deprivation therapyMasaki Shiota, Akira Yokomizo, Ario Takeuchi, et al.International Journal of Oncology|February 21, 2012
Sunitinib enhances antitumor effects against chemotherapy-resistant bladder cancer through suppression of ERK1/2 phosphorylationArio Takeuchi, Masatoshi Eto, Masaki Shiota, et al.Andrologia|June 24, 2019
Psoas muscle volume is correlated with sexual activity and erectile dysfunction among patients with localised prostate cancerEiji Kashiwagi, Kenjiro Imada, Keisuke Monji, et al.Cancer Research|August 17, 2012
Clusterin mediates TGF-β-induced epithelial-mesenchymal transition and metastasis via Twist1 in prostate cancer cellsMasaki Shiota, Anousheh Zardan, Ario Takeuchi, et al.European Journal of Cancer (Oxford, England : 1990)|July 15, 2015
SRD5A gene polymorphism in Japanese men predicts prognosis of metastatic prostate cancer with androgen-deprivation therapyMasaki Shiota, Naohiro Fujimoto, Akira Yokomizo, et al.Journal of Endourology|April 7, 2011
Impact of cold and warm ischemia on postoperative recovery of affected renal function after partial nephrectomyKatsunori Tatsugami, Masatoshi Eto, Akira Yokomizo, et al.European Journal of Immunology|December 25, 2010
IL-17 production by γδ T cells is important for the antitumor effect of Mycobacterium bovis bacillus Calmette-Guérin treatment against bladder cancerArio Takeuchi, Takashi Dejima, Hisakata Yamada, et al.International Journal of Oncology|July 3, 2010
Sensitivity of doxorubicin-resistant cells to sorafenib: possible role for inhibition of eukaryotic initiation factor-2alpha phosphorylationMasaki Shiota, Masatoshi Eto, Akira Yokomizo, et al.Cancer Chemotherapy and Pharmacology|May 6, 2011
Sorafenib augments cytotoxic effect of S-1 in vitro and in vivo through TS suppressionArio Takeuchi, Masaki Shiota, Katsunori Tatsugami, et al.Pageof 12